ETHZilla Corp — Director's Dealing 2023

Sep 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2023-09-04

Reporting Person: RAY RUSSELL T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-04	Common Stock	A	21455	$1.36	Acquired	24409	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-09-04	Non-Qualified Stock Option (right to buy)	$0.67	A	15000	Acquired	2033-09-04	Common Stock (15000)	Direct

Footnotes

F1: Issued in consideration for serving on the Board of Directors and as a Member of the Audit, Compensation and Nominating and Corporate Governance Committees of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.

F2: Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.

F3: The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.